5.4. Analysis.
Comparison 5 Three infusions of natalizumab (300 mg) and two infusions of infliximab versus placebo and two infusions of infliximab, Outcome 4 Withdrawal due to adverse events.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.